Peer Review History
| Original SubmissionJune 10, 2020 |
|---|
|
PONE-D-20-17772 Evidence and magnitude of seasonality in SARS-CoV2 transmission: Penny wise, pandemic foolish? × PLOS ONE Dear Dr. Kaplin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The Authors are expected to address all the criticisms by all Reviewers. In particular, avoid implication on causality, justify, or avoid exclusion of countries, including countries in the Southern Hemisphere (Reviewers #2 and #3), improve the writing of the manuscript, revise Figure 2 for accuracy and clarify (Reviewer #1), assess the impact of the choice of time period on the results (Reviewer #2), avoid conclusion on seasonality, and provide the equations for the major models used for the analysis (Reviewer #3). In additional to the above comments, please address,
Please submit your revised manuscript by Oct 02 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Eric HY Lau, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please refer to the specific statistical analyses performed as well as any post-hoc corrections to correct for multiple comparisons. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting), and please ensure that the statistical analysis is fully reported in the Methods section. 3. Please consider modifying your title to ensure that it is specific, descriptive, concise, and comprehensible to readers outside the field. 4.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5.Thank you for stating the following in the Competing Interests section: [The authors have declared that no competing interests exist.]. We note that one or more of the authors are employed by a commercial company: PUPA
Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests Additional Editor Comments (if provided): The Authors are expected to address all the criticisms by all Reviewers. In particular, avoid implication on causality, justify, or avoid exclusion of countries, including countries in the Southern Hemisphere (Reviewers #2 and #3), improve the writing of the manuscript, revise Figure 2 for accuracy and clarify (Reviewer #1), assess the impact of the choice of time period on the results (Reviewer #2), avoid conclusion on seasonality, and provide the equations for the major models used for the analysis (Reviewer #3). In additional to the above comments, please address, 1. L87-90, the exclusion of China, Russia and Italy is not well justified. The case numbers in different countries are available from different sources which were translated into English. There are other exclusions which were not fully justified. 2. Please remove citations 6 and 7 3. Carry out relevant sensitivity analysis to justify the conclusion that the results were robust. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Partly Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: If only it were that simple! On the whole, linear regressions can generate hypotheses, but they can't test them in the way that you are attempting to do. Figure 2 looks very impressive until you realize that it is extracted from a model where you've got quite a few variables, and not that many data points. The correlation shown is - or seems to be - meaningful and important. The raw and derived data (including your CT measure) is much less impressive. I may have misunderstood Figure 2, but then it is very poorly explained – see my comments below. I hesitate to criticize you for this, because a lot of well-known epidemiologists are guilty of the same thing, but it would help a lot if you were clearer about the phenomena that you are modelling, and what we don’t know. Epidemiologists use very simple models where they assume that someone who is infected always becomes symptomatic after a certain interval. This is in reality not the case. A very interesting series of articles were published recently by Jeff Shaman’s group at Columbia University who sampled the population of New York City, looking for the presence of respiratory viruses. They found that the majority of people carrying detectable virus had no symptoms. They also found that as many people had detectable virus in summer as in winter. I feel your article (or similar articles in future) would be improved if you thought more about the possible mechanisms that give rise to seasonality, and were clearer about what we DON’T know. I’ve put some references below. Can I ask that in future you take a little more trouble in writing your articles? There are lots of problems with this manuscript. For a start, there are many sentences that don't have verbs in them. For example, p8, line 119. In the abstract, P2, lines 44-45 don't make sense. Then on the most important item in your paper, Figure 2, the vertical axis is not labelled correctly. In fact Fig 2 says that as temp increases the number of cases increases! You are also inconsistent in abbreviations - sometimes you write DP, other times DEWP. It's not fair on the reviewers to ask them to put in a lot of effort if you don't make your article easy to read. There is also a lot of repetition in the article between the table and figure legends and the main text. Just write everything once, clearly. I always start by writing the legends, because they are what most people read first. Either put the detail in there, or refer, in the legends, to the main text for the detail. Most people write the main text first, then they realize that they need to explain the figures, and write the same material over again - I think this might be what you have done. Galanti, M., et al. "Rates of asymptomatic respiratory virus infection across age groups." Epidemiology & Infection 147 (2019). Galanti, M, et al. "Longitudinal active sampling for respiratory viral infections across age groups." Influenza and Other Respiratory Viruses 13.3 (2019): 226-232. Shaw Stewart, PD. Seasonality and selective trends in viral acute respiratory tract infections. Medical Hypotheses 2016; 86 104–119. https://www.douglas.co.uk/f_ftp1/ShawStewart_final_1-s2.pdf Reviewer #2: The paper is of interest and I would like to see a number of improvements to this work before it can be published. The paper looks at the association between the COVID-19 case number and the temperature. This topic is not novel and has been widely studied (e.g., [1-5]). However, the current manuscript does not give a clear and comprehensive review of the most up-to-date background and studies of this topic. The author should clearly address the innovative contribution of their study and compare with other relevant studies (e.g., whether a new method is used? what is the advantage of this new method? Does the study cover a more comprehensive dataset? Does the study give any new conclusion or verify existing results?) These should be discussed in the Introduction and Discussion of this manuscript. In the Method section, the authors state that they exclude data from China and Russia and list the relevant news report as a support. It is generally acceptable to cite information from the media for the COVID study when the information is simply an objective report of what has happened. However, the citation 6 and 7 in the manuscript are based on some so called “source of the leak” and cannot be verified. It is just a speculation made by someone not from the scientific community. The WHO has never made a similar statement. Therefore, it is not scientific to exclude data from China and Russia based on current “support”. The authors should cite reliable and objective information (e.g., published papers, as the author already do to explain Italy) or give some more convincible reasons. Similarly, I am interested to know the reason of excluding Canada and the United States of America. The authors state that the method used in this study is robust. By looking at the Figure 1, I doubt if the conclusion made in the manuscript is really robust. The cumulative number of COVID 19 cases generally shows a concave trend. Hence, if you look at the first half of the time period, the coefficients of time (CT) will be larger. Similarly, the CT will be smaller if you look at the other half of the time period. It is therefore needed to investigate whether the conclusion still holds when the time period changes. If the conclusion is largely affected, this point should be stated as a caution in the manuscript. Meanwhile, the author may consider including the quadratic term in the first regression. The authors should be cautious when saying “a one degree increase leads to a 1% decrease--and a one degree decrease leads to a 3.7% increase” in the Abstract. “Lead” normally indicates causality. It should be replaced by “associate”. Minor Comments: In line 57, it should be “Coronavirus” rather than “Corona VIrus” In Figure 2, the y axis label should be “reciprocal of CT (CT-1)” rather than “confirmed cases (Log)”. Additional Reference: 1. Wu Y, Jing W, Liu J, et al. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries. Sci Total Environ. 2020;729:139051. doi:10.1016/j.scitotenv.2020.139051 2. Shi P, Dong Y, Yan H, et al. Impact of temperature on the dynamics of the COVID-19 outbreak in China. Sci Total Environ. 2020;728:138890. doi:10.1016/j.scitotenv.2020.138890 3. Xie J, Zhu Y. Association between ambient temperature and COVID-19 infection in 122 cities from China. Sci Total Environ. 2020;724:138201. doi:10.1016/j.scitotenv.2020.138201 4. Ujiie M, Tsuzuki S, Ohmagari N. Effect of temperature on the infectivity of COVID-19. Int J Infect Dis. 2020;95:301-303. doi:10.1016/j.ijid.2020.04.068 5. Sajadi MM, Habibzadeh P, Vintzileos A, Shokouhi S, Miralles-Wilhelm F, Amoroso A. Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020;3(6):e2011834. Published 2020 Jun 1. doi:10.1001/jamanetworkopen.2020.11834 Reviewer #3: Thank you for giving me an opportunity to review this submission titled “Evidence and magnitude of seasonality in SARS-CoV2 transmission: Penny wise, pandemic foolish?”. The study is very timely given the current pandemic situation and indeed tackles an important issue, and to some extent controversy, about environmental and atmospheric conditions conducive for COVID-19 transmission. I acknowledge that the article has its own merits and immense potential to be able to contribute to current body of knowledge; however, there are still quite a few issues I found perplexing and needs to be addressed better before I give my full recommendation for publication. The first thing that stands out is the use of the work “seasonality” which to me might be a little bit misleading as effectively only one season was evaluated. It is a strong claim to make given very limited evidence presented in the study and it did not help that the design further limited this viewpoint by not considering Southern Hemisphere countries/regions. Rather, a more appropriate wording must have focused around correlation between meteorological or environmental or atmospheric conditions with COVID-19 transmission. I have some more specific questions and concerns detailed below. Pending satisfactory responses, I can then give my recommendation to have this published. Abstract: • Line 38: Can you expound more, either in the Methods or Results section, how the reciprocal of CT can be associated with doubling time? If possible, is there some exact mathematics as to how they are related? • Lines 49-50: While it does make sense to make the claim about summer months, I find it hard to make a claim on winter months given there is no actual evidence to support this. Data were limited to the Northern Hemisphere countries which are yet to experience winter, and all that we have are claims based on temperature changes which is not fully indicative of a seasonal change. Actually, this applies to the summer claim as well. Perhaps, this statement can be restated so that it does not appear to be overpromising and just stick with correlations between temperature or humidity with transmission? Methods: • Lines 84-87: However, my take is that wouldn't using Southern Hemisphere countries even as controls be also helpful, as at the same time they experienced drop in temperatures? Especially, if the study is also making a claim about possible 'resurgence' during colder months? In fact, I am not convinced why does the data cannot from two hemispheres cannot be pooled. • Lines 87-90: While not so much of an issue at the moment, but have you considered exploring or conducting some kind of sensitivity analyses to check how the results would have changed if these countries are added in the analyses – at least even just with Italy? • Lines 91-92: What did you mean by countries with separate reports of cases from multiple regions? Can you list what these countries are? • Line 93: How did you assess reliability of COVID-19 and meteorological data? • Lines 107-111: Were there opportunities to also used other variables? While it does help that you provided a reference as to why Tmin is one of the most appropriate to use in this context, I would be inclined to also explore other measures (such as Tmean, Tmed, Tmax) and see how the correlation magnitudes change or not. To my mind, this could have presented a more comprehensive picture of how temperature is correlated with transmission. This also applies to other atmospheric data which NOAA is tracking and ‘complete’ for all countries anaysed. • Lines 113-114: I’m sorry but I did not understand this fully. So does this mean whenever there were 0 cases in a day, corresponding Tmin and DP were not also recorded? Why is this so? Even if, say, there is one day that no confirmed cases were reported squeezed between two days with high cases, that day with 0 case is already dropped? But I still don’t see why this is needed to be performed given it is the reciprocal of CT (based on cumulative counts) that is being modelled. So in other words, the entire span of the series for CT per country should also be the same timeline of the temperature and dewpoint data to be considered. Or maybe this is already performed, but I am just understanding this incorrectly? Can you please explain further? Best if you can give me an actual scenario/example? • Can you add a subsection describing with thorough details the model formulations (including even just ‘generic’ equations but appropriately contextualised)? Results: • Lines 150-152: Are there other measures you can consider to assess the goodness-of-fit? To my mind, while R2 is okay, we will actually expect it to be very high given we are fitting to a function of cumulative confirmed cases which are naturally increasing in in time. So no matter what the shape is, especially with log(cumulative cases), the linear increasing trend will be captured very well. I will be more inclined to report other goodness-of-fit measures too just as an added support to this great fit. • Figure 2: It seems to me that there is a systematic bias here, where for higher values the best-fit (predicted) values are always less than those? In other words, for higher confirmed inverse CT there appears to be a systematic underestimation. Wouldn’t this affect model interpretation and appropriateness for higher values of either inverse CT or temperature? • Lines 224-225: How often do you see this much change in temperature (drop or increase of 70°F)? To me, I would prefer to present them in a much more interpretable format, say the relative size of temperature changes going from one latitudinal zone to another. Or even simpler, in around 5-10°F changes? Discussion: • Line 240: How do you qualify ‘strong and robust’ with your findings? To me, I feel that this is such a strong claim and a bit of an overstretch given the issues I pointed out earlier about data catchment and quality as well as standard correlational approaches via regression. Perhaps, consider rephrasing this so as not to oversell the results? • Line 242: Again, I find ‘impacts’ a bit too strong given there is no causality established - what we only know is that there is statistical evidence (from correlations) that they are related. • Line 272: In claiming similarities in seasonal pattern of infections with SARS-CoV, perhaps you can add more context into this. As your study focused only on temperature (and to some extent, humidity) perhaps it is better if you discuss this in the context of changes in temperature (or ranges) here from summer to winter. Again, it is hard to make claims about summer and winter differences when all your data are based on summer and the only proxy for winter conditions is based on temperature. Furthermore, I suppose this seasonal pattern can be different in many regions, and what happens for tropical climates where there is no winter? • Lines 293-297: Can you further explain this sentence? Of course, they will be different from a calculation perspective given you have different denominators in quantifying changes between increasing-to-decreasing and decreasing-to-increasing even for the same magnitude (70°F) of difference. To my mind, they are all based on the estimated regression coefficients so in principle the changes should be similar. • Line 299: Again, I find the claim that “could pay off significantly in the fall and winter” a bit of an overstretch given the same issues I raised before about not having analysed winter conditions (e.g., by not considering the Southern Hemisphere). Some minor comments: • In general, when presenting temperatures, would you consider mentioning them in °C too, especially for audience who use this scale? This adds more context in the study. • Also, maybe reconsider restructuring the Methods and Results sections, as some contents are better written under Methods (e.g. model-fitting stages) while others are in Results (e.g. Table 1). • Line 60 (Introduction): I believe you meant ‘MERS-CoV’ here? • Lines 65-66 (Introduction): Perhaps you can expound a bit more on these evidence or suggestions, especially its quality? How about counter evidence or arguments? • Line 79 (Methods): What do longitudinal changes mean? By time? Perhaps you can use a different word to make this clearer. • Lines 95-97 (Methods): Perhaps clearly mention that you are referring to ‘daily’ (new) confirmed cases. • Lines 100-102 (Methods): To be honest, I am more inclined to not discuss anything about longitude coverage given it does not affect meteorological conditions, right? This is to save space or number of words. • Lines 173-175 (Results): I think it would have been more appropriate (but admittedly, more complex) if the counts have been age-standardised with respect to a reference population? So no need for such covariate? Has this been explored/considered? • Table 2: I believe the 4th column refers to estimated regression coefficients right? Perhaps just mention this instead of correlation as it might be a bit misleading? • Table 2: I am not too keen about reporting analyses with Recovered data in the same amount of details as with Confirmed Cases and Deaths just because they may be of the poorest quality among the three, at least in many countries that I know of, Recoveries are almost not always reported. So this might give an impression that the data is also robust if included as part of the main analysis. May I suggest instead to remove this in the Table and just simply write out a paragraph for somewhere in the Results section. • Table 2: In my experience, annotating p-values > 0.05 is not a standard wat of reporting. Oftentimes you annotate those which are statistically significant, not the other way around. Also, the use of scientific notation/exponentiation in p-values appear to obscure the values p-values (making them appear less in magnitude), so may I suggest changing to 3 or 4 decimal places and whenever less than 0.001 just say <0.001? • Lines 236-237 (Results): Shouldn’t this be part of Methods? • Lines 279-281 (Discussion): I think the way it is currently written it does not make sense. Longitudinal differences do not dictate atmospheric and meteorological conditions, so if the reference is to the model using temperature then it does not apply. But if the reference is to the approach but using difference covariates (say, cultural or population behaviour measures) then I see how it can also be useful. What I am trying to say is perhaps you can rephrase this better to avoid this ambiguity in interpretations. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-17772R1 Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission: Penny wise, pandemic foolish? PLOS ONE Dear Dr. Kaplin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The Authors are expected to address all the criticisms by all Reviewers. In particular, the statement “We were therefore able to capture a period where weather and not social interventions played the predominant role in impacting transmission” may not be fully justified (Reviewers #3). In additional to the above comments, please address,
Please submit your revised manuscript by Dec 21 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Eric HY Lau, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (if provided): The Authors are expected to address all the criticisms by all Reviewers. In particular, the statement “We were therefore able to capture a period where weather and not social interventions played the predominant role in impacting transmission” may not be fully justified (Reviewers #3). In additional to the above comments, please address, 1. Title, please remove “Penny wise, pandemic foolish?” as it is not a conclusion or description of the study 2. L87-90, the exclusion of China, Russia and Italy and Southern Hemisphere countries is not well justified. The case numbers in different countries are available from different sources which were translated into English. Even Italy has a larger number of cases, the potential impact of meteorological variables should equally apply to the trend within country. 3. How to assess consistency in reporting should be made explicit as inclusion or exclusion criteria. 4. What was the reason to use data up to Apr 6? Variation in the meteorological variables is expected to be larger over summer and should better demonstrate the effect of interest. 5. Table 1, Finland has a CT^-1 of 16.13 and Tmin = 19.3. However, this data point was missing in Figure 2. Also for Vietnam, the CT^-1 was 36.94 but the data point was missing in Figure 2. Please confirm accuracy of the data/analysis. 6. Table 2, please clarify the label ‘correlation’. For LAPC, it was 21.244 when assessing confirmed cases which is out of usual range for correlation. Is it coefficient instead? 7. Table 2, if the label ‘correlation’ is correct, please note that the correlations, even statistically significant, was mostly small (< 0.3), indicating a weak correlation. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: (No Response) Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: (No Response) Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript seems to be clearer with improved grammar. The figures seem to be correctly labelled. Reviewer #2: (No Response) Reviewer #3: I commend the authors for a much improved version of the manuscript. It is now at a more readable state without compromising nor overselling the strength of their findings. While I still personally think that it was not fully justified that Southern Hemisphere countries should be excluded, as I think they can still be considered even as a sub-analysis of its own or just part of the sensitivity analysis which if things went as expected should be able to further strengthen their claims, I still think that my personal opinion should not hinder the publication of such a very timely and still informative article. Indeed, their key findings along of potential seasonality in pathogen transmission of SARS-CoV-2 are intriguing and very useful enough to be published, as this should warrant further investigation of plausible biological underpinnings of these findings. I do have some minor comments that I hope the authors consider in preparing the final version of this piece: 1.) In the Introduction, lines 80-95, while I understand that the cited literature presented findings in units of Celsius for temperature, the authors can consider, even written in parentheses, converted units to Fahrenheit for consistency in the use of temp units all throughout the study, w/c may also improve comparability of their findings with others'. 2.) At first, I thought that their inclusion criteria were based on daily new case counts (hence, the reason for the way I stated my question previously w/c also confused the authors), but it was made clear to me that they were actually working with cumulative case counts. If that is the case, I think dropping the term 'daily' should already suffice as the explanation is now clear as long as the term 'cumulative' is retained. 3.) In Line 175, what does '/' mean in CT/CT^(-1)? I trust that this is read as 'or' rather than the mathematical symbol for division (as it will just turn out to be CT^2 w/c doe snot makes sense nor even appeared anywhere in the manuscript). Am I right about this? If so, perhaps change '/' to spell out 'or' in full to avoid confusion. 4.) To my mind, the last two subsections in the Results section (relationship of CT to Td, and model equation formulation) fit better as last subsections of the Methods section as they set the stage on as how to interpret their results moving forward. Can the authors consider moving these? 5.) Lastly, in lines 367-368, I still find the statement "We were therefore able to capture a period where weather and not social interventions played the predominant role in impacting transmission." a very strong statement considering the authors considered a long time frame, and there are other regions/countries who almost immediately, and their citizens' abided by, imposed rules on social gathering restrictions and physical distancing. In other words, this claim is untestable and is far too stretched, perhaps my suggestion is to 'soften' the claim by using more nuanced words/qualifiers such as "where weather MAY have played more role in impacting transmission as evidenced by ..." These are all I have. Again, thank you for the opportunity to review this well-written piece. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-20-17772R2 Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission PLOS ONE Dear Dr. Kaplin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The Authors have clarified most of the concern. However, it would be helpful to also include these explanations especially on the exclusion criteria in the manuscript, considering the following:
Please submit your revised manuscript by Feb 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Eric HY Lau, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (if provided): The Authors have clarified most of the concern. However, it would be helpful to also include these explanations especially on the exclusion criteria in the manuscript, considering the following: 1. In the response, the authors provided valid reasons for the exclusion of China and Russia, especially the large variation in latitude and hence meteorological parameters. In the manuscript, please state this explicitly as an exclusion criterion. Under-reporting of infections is likely common but the extent can vary greatly across countries. However, this would only affect the results if the level of under-reporting changed significantly over time within country. Please also note that Krantz et al and Lau et al. only gave consistent conclusion on under-reporting for the US and Spain, but very different for China (least under-reporting in Lau et al.), Italy and France. In any case, please provide evidence in the manuscript on the under-reporting / change in under-reporting over time if this is still the main reason for exclusion. 2. Please reconsider if language is really a criterion for exclusion. I believe different languages were used in the included countries. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission PONE-D-20-17772R3 Dear Dr. Kaplin, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Eric HY Lau, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-17772R3 Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission Dear Dr. Kaplin: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Eric HY Lau Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .